Prognostic clinicopathologic factors in carcinoma of unknown primary origin

A study of 106 consecutive cases

Junjeong Choi, Ji Hae Nahm, Sang Kyum Kim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A heterogeneous group of cancers for which the site of origin remains occult after detailed investigations is defined as carcinomas of unknown primary origin (CUPs). Because patients with CUP have a dismal prognosis, we have analyzed CUPs to highlight the implication of clinicopathologic factors related with patient survival. A total of 106 consecutive cases of CUP were collected. A two-step strategy of immunohistochemistry to assess CUPs according NCCN Guidelines is used to separate carcinomatous tumors and subtype carcinomas. Median follow up of censored patients was 26 months. Median survival time of whole patients was 13 months (95% confidence interval [CI], 8.43 - 19.1 months), with one, two and fiveyear survival rate of 53.7%, 35.1%, and 30.5%, respectively. Factors related with shorter overall survival was adenocarcinoma histology (P=0.001), increased CA19- 9 (P=0.003), increased CEA (P=0.047), increased LDH (P < 0.001), CK20 positivity (P=0.002), presence of bone metastasis (P=0.017), metastasis not confined to the lymph nodes (P=0.015), unfavorable clinical group based predefined category (P=0.017), and patients with no treatment (P < 0.001). Multivariable analysis with cox regression model revealed factors related with overall survival; cases belonged to Culine's poor risk group (HR, 3.88; 95% CI, 1.75-8.64; P=0.001) and CK20 positivity (HR, 3.31; 95% CI, 1.42-7.70; P=0.005). In conclusion, the CK20 expression profile is a prognostic factor in patients with CUP and initial stratification of patient with Culine's model may provide a prognostic information in these patients. Assessment of clinical implication of these factors in the context of site specific therapy needs to be evaluated.

Original languageEnglish
Pages (from-to)62630-62640
Number of pages11
JournalOncotarget
Volume8
Issue number37
DOIs
Publication statusPublished - 2017 Sep 1

Fingerprint

Carcinoma
Survival
Confidence Intervals
Neoplasm Metastasis
Neoplasms
Proportional Hazards Models
Histology
Adenocarcinoma
Survival Rate
Lymph Nodes
Immunohistochemistry
Guidelines
Bone and Bones
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

@article{6cddd423ee8d4376af99c0807d09d1bf,
title = "Prognostic clinicopathologic factors in carcinoma of unknown primary origin: A study of 106 consecutive cases",
abstract = "A heterogeneous group of cancers for which the site of origin remains occult after detailed investigations is defined as carcinomas of unknown primary origin (CUPs). Because patients with CUP have a dismal prognosis, we have analyzed CUPs to highlight the implication of clinicopathologic factors related with patient survival. A total of 106 consecutive cases of CUP were collected. A two-step strategy of immunohistochemistry to assess CUPs according NCCN Guidelines is used to separate carcinomatous tumors and subtype carcinomas. Median follow up of censored patients was 26 months. Median survival time of whole patients was 13 months (95{\%} confidence interval [CI], 8.43 - 19.1 months), with one, two and fiveyear survival rate of 53.7{\%}, 35.1{\%}, and 30.5{\%}, respectively. Factors related with shorter overall survival was adenocarcinoma histology (P=0.001), increased CA19- 9 (P=0.003), increased CEA (P=0.047), increased LDH (P < 0.001), CK20 positivity (P=0.002), presence of bone metastasis (P=0.017), metastasis not confined to the lymph nodes (P=0.015), unfavorable clinical group based predefined category (P=0.017), and patients with no treatment (P < 0.001). Multivariable analysis with cox regression model revealed factors related with overall survival; cases belonged to Culine's poor risk group (HR, 3.88; 95{\%} CI, 1.75-8.64; P=0.001) and CK20 positivity (HR, 3.31; 95{\%} CI, 1.42-7.70; P=0.005). In conclusion, the CK20 expression profile is a prognostic factor in patients with CUP and initial stratification of patient with Culine's model may provide a prognostic information in these patients. Assessment of clinical implication of these factors in the context of site specific therapy needs to be evaluated.",
author = "Junjeong Choi and Nahm, {Ji Hae} and Kim, {Sang Kyum}",
year = "2017",
month = "9",
day = "1",
doi = "10.18632/oncotarget.16021",
language = "English",
volume = "8",
pages = "62630--62640",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "37",

}

Prognostic clinicopathologic factors in carcinoma of unknown primary origin : A study of 106 consecutive cases. / Choi, Junjeong; Nahm, Ji Hae; Kim, Sang Kyum.

In: Oncotarget, Vol. 8, No. 37, 01.09.2017, p. 62630-62640.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prognostic clinicopathologic factors in carcinoma of unknown primary origin

T2 - A study of 106 consecutive cases

AU - Choi, Junjeong

AU - Nahm, Ji Hae

AU - Kim, Sang Kyum

PY - 2017/9/1

Y1 - 2017/9/1

N2 - A heterogeneous group of cancers for which the site of origin remains occult after detailed investigations is defined as carcinomas of unknown primary origin (CUPs). Because patients with CUP have a dismal prognosis, we have analyzed CUPs to highlight the implication of clinicopathologic factors related with patient survival. A total of 106 consecutive cases of CUP were collected. A two-step strategy of immunohistochemistry to assess CUPs according NCCN Guidelines is used to separate carcinomatous tumors and subtype carcinomas. Median follow up of censored patients was 26 months. Median survival time of whole patients was 13 months (95% confidence interval [CI], 8.43 - 19.1 months), with one, two and fiveyear survival rate of 53.7%, 35.1%, and 30.5%, respectively. Factors related with shorter overall survival was adenocarcinoma histology (P=0.001), increased CA19- 9 (P=0.003), increased CEA (P=0.047), increased LDH (P < 0.001), CK20 positivity (P=0.002), presence of bone metastasis (P=0.017), metastasis not confined to the lymph nodes (P=0.015), unfavorable clinical group based predefined category (P=0.017), and patients with no treatment (P < 0.001). Multivariable analysis with cox regression model revealed factors related with overall survival; cases belonged to Culine's poor risk group (HR, 3.88; 95% CI, 1.75-8.64; P=0.001) and CK20 positivity (HR, 3.31; 95% CI, 1.42-7.70; P=0.005). In conclusion, the CK20 expression profile is a prognostic factor in patients with CUP and initial stratification of patient with Culine's model may provide a prognostic information in these patients. Assessment of clinical implication of these factors in the context of site specific therapy needs to be evaluated.

AB - A heterogeneous group of cancers for which the site of origin remains occult after detailed investigations is defined as carcinomas of unknown primary origin (CUPs). Because patients with CUP have a dismal prognosis, we have analyzed CUPs to highlight the implication of clinicopathologic factors related with patient survival. A total of 106 consecutive cases of CUP were collected. A two-step strategy of immunohistochemistry to assess CUPs according NCCN Guidelines is used to separate carcinomatous tumors and subtype carcinomas. Median follow up of censored patients was 26 months. Median survival time of whole patients was 13 months (95% confidence interval [CI], 8.43 - 19.1 months), with one, two and fiveyear survival rate of 53.7%, 35.1%, and 30.5%, respectively. Factors related with shorter overall survival was adenocarcinoma histology (P=0.001), increased CA19- 9 (P=0.003), increased CEA (P=0.047), increased LDH (P < 0.001), CK20 positivity (P=0.002), presence of bone metastasis (P=0.017), metastasis not confined to the lymph nodes (P=0.015), unfavorable clinical group based predefined category (P=0.017), and patients with no treatment (P < 0.001). Multivariable analysis with cox regression model revealed factors related with overall survival; cases belonged to Culine's poor risk group (HR, 3.88; 95% CI, 1.75-8.64; P=0.001) and CK20 positivity (HR, 3.31; 95% CI, 1.42-7.70; P=0.005). In conclusion, the CK20 expression profile is a prognostic factor in patients with CUP and initial stratification of patient with Culine's model may provide a prognostic information in these patients. Assessment of clinical implication of these factors in the context of site specific therapy needs to be evaluated.

UR - http://www.scopus.com/inward/record.url?scp=85028748036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028748036&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.16021

DO - 10.18632/oncotarget.16021

M3 - Article

VL - 8

SP - 62630

EP - 62640

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 37

ER -